{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:22Z","timestamp":1780984762444,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141004"],"award-info":[{"award-number":["32141004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2018-40-2101"],"award-info":[{"award-number":["Z-2018-40-2101"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peking University Clinical Scientist Training Program","award":["BMU2023PYJH010"],"award-info":[{"award-number":["BMU2023PYJH010"]}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20230155"],"award-info":[{"award-number":["GZC20230155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08032-y","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:53:11Z","timestamp":1775447591000},"page":"3257-3267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mycophenolate mofetil associates with COVID-19 hospitalization in patients with systemic lupus erythematosus: a nationwide population-based study from China"],"prefix":"10.1007","volume":"45","author":[{"given":"Sitian","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5417-9160","authenticated-orcid":false,"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"5","key":"8032_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.semarthrit.2020.06.012","volume":"50","author":"GA Ramirez","year":"2020","unstructured":"Ramirez GA, Gerosa M, Beretta L et al (2020) COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients. Semin Arthritis Rheum 50(5):1150\u20131157. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.012","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"8032_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/aitc202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL (2020) Systemic Lupus Erythematosus. Ann Intern Med 172(11):81\u201396. https:\/\/doi.org\/10.7326\/aitc202006020","journal-title":"Ann Intern Med"},{"issue":"6","key":"8032_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jama.2011.765","volume":"306","author":"S Ringold","year":"2011","unstructured":"Ringold S, Lynm C, Golub RM (2011) Systemic lupus erythematosus. JAMA 306(6):668. https:\/\/doi.org\/10.1001\/jama.2011.765","journal-title":"JAMA"},{"issue":"9","key":"8032_CR4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3899\/jrheum.151523","volume":"43","author":"D Chen","year":"2016","unstructured":"Chen D, Xie J, Chen H et al (2016) Infection in Southern Chinese patients with Systemic Lupus Erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol 43(9):1650\u20131656. https:\/\/doi.org\/10.3899\/jrheum.151523","journal-title":"J Rheumatol"},{"issue":"2","key":"8032_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/rai2.70004","volume":"5","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang M, Zang S et al (2025) Assessment of factors influencing outcomes of SARS\u2010CoV\u20102 Omicron subvariants BA.5.2\/BF.7 infection in rheumatoid arthritis patients. Rheumatol Autoimmun 5(2):157\u2013159. https:\/\/doi.org\/10.1002\/rai2.70004","journal-title":"Rheumatol Autoimmun"},{"issue":"1","key":"8032_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jobb.2023.01.002","volume":"5","author":"Y Sun","year":"2023","unstructured":"Sun Y, Wang M, Lin W et al (2023) Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China. J Biosaf Biosecur 5(1):14\u201320. https:\/\/doi.org\/10.1016\/j.jobb.2023.01.002","journal-title":"J Biosaf Biosecur"},{"issue":"10","key":"8032_CR7","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3201\/eid2910.230585","volume":"29","author":"Z Du","year":"2023","unstructured":"Du Z, Wang Y, Bai Y et al (2023) Estimate of COVID-19 deaths, China, December 2022-February 2023. Emerg Infect Dis 29(10):2121\u20132124. https:\/\/doi.org\/10.3201\/eid2910.230585","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"8032_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/annrheumdis-2021-221636","volume":"81","author":"MF Ugarte-Gil","year":"2022","unstructured":"Ugarte-Gil MF, Alarc\u00f3n GS, Izadi Z et al (2022) Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Ann Rheum Dis 81(7):970\u2013978. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221636","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"8032_CR9","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/0961203320961848","volume":"29","author":"A Mason","year":"2020","unstructured":"Mason A, Rose E, Edwards CJ (2020) Clinical management of lupus patients during the COVID-19 pandemic. Lupus 29(13):1661\u20131672. https:\/\/doi.org\/10.1177\/0961203320961848","journal-title":"Lupus"},{"issue":"2","key":"8032_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/mr\/road030","volume":"34","author":"XW Zhao","year":"2024","unstructured":"Zhao XW, Wu HH, Li SF et al (2024) The impact of the COVID-19 pandemic on SLE. Mod Rheumatol 34(2):247\u2013264. https:\/\/doi.org\/10.1093\/mr\/road030","journal-title":"Mod Rheumatol"},{"issue":"17","key":"8032_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175572","volume":"12","author":"R Flisiak","year":"2023","unstructured":"Flisiak R, Zarebska-Michaluk D, Dobrowolska K et al (2023) Change in the clinical picture of hospitalized patients with COVID-19 between the early and late period of dominance of the Omicron SARS-CoV-2 variant. J Clin Med 12(17):5572. https:\/\/doi.org\/10.3390\/jcm12175572","journal-title":"J Clin Med"},{"issue":"9","key":"8032_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/s2665-9913(22)00190-4","volume":"4","author":"A Saxena","year":"2022","unstructured":"Saxena A, Engel AJ, Banbury B et al (2022) Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. Lancet Rheumatol 4(9):582\u2013585. https:\/\/doi.org\/10.1016\/s2665-9913(22)00190-4","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"8032_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08107-x","volume":"22","author":"J Lambert","year":"2022","unstructured":"Lambert J, Sandhu H, Kean E et al (2022) A strategy to identify event specific hospitalizations in large health claims databases. BMC Health Serv Res 22(1):705. https:\/\/doi.org\/10.1186\/s12913-022-08107-x","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"8032_CR14","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"key":"8032_CR15","unstructured":"Frontmatter (1987) Multiple imputation for nonresponse in surveys. Wiley Series in Probability and Statistics."},{"issue":"5","key":"8032_CR16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/rheumatology\/keq376","volume":"50","author":"CS Yee","year":"2011","unstructured":"Yee CS, Farewell VT, Isenberg DA et al (2011) The use of systemic lupus erythematosus disease activity index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford) 50(5):982\u2013988. https:\/\/doi.org\/10.1093\/rheumatology\/keq376","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8032_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12026-023-09449-2","volume":"72","author":"YL Wu","year":"2023","unstructured":"Wu YL, Li YH, Wu T et al (2023) COVID-19 in systemic lupus erythematosus patients treated with belimumab: a retrospective clinical study. Immunol Res 72(3):418\u2013429. https:\/\/doi.org\/10.1007\/s12026-023-09449-2","journal-title":"Immunol Res"},{"issue":"7","key":"8032_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79(7):859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"issue":"36","key":"8032_CR19","doi-asserted-by":"publisher","first-page":"2300048","DOI":"10.2807\/1560-7917.Es.2023.28.36.2300048","volume":"28","author":"T Nyberg","year":"2022","unstructured":"Nyberg T, Bager P, Svalgaard IB et al (2022) A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022. Euro Surveill 28(36):2300048. https:\/\/doi.org\/10.2807\/1560-7917.Es.2023.28.36.2300048","journal-title":"Euro Surveill"},{"issue":"2","key":"8032_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00927-22","volume":"8","author":"HM Rando","year":"2023","unstructured":"Rando HM, Lordan R, Lee AJ et al (2023) Application of traditional vaccine development strategies to SARS-CoV-2. mSystems 8(2):0092722. https:\/\/doi.org\/10.1128\/msystems.00927-22","journal-title":"mSystems"},{"key":"8032_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mran.2023.100249","volume":"23","author":"M Popovic","year":"2023","unstructured":"Popovic M (2023) The SARS-CoV-2 hydra, a tiny monster from the 21st century: thermodynamics of the BA.5.2 and BF.7 variants. Microb Risk Anal 23:100249. https:\/\/doi.org\/10.1016\/j.mran.2023.100249","journal-title":"Microb Risk Anal"},{"issue":"17","key":"8032_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173842","volume":"10","author":"R Cordtz","year":"2021","unstructured":"Cordtz R, Kristensen S, Dalgaard LPH et al (2021) Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark. J Clin Med 10(17):3842. https:\/\/doi.org\/10.3390\/jcm10173842","journal-title":"J Clin Med"},{"issue":"5","key":"8032_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.seminoncol.2020.06.002","volume":"47","author":"JD Strope","year":"2020","unstructured":"Strope JD, Chau CH, Figg WD (2020) Are sex discordant outcomes in COVID-19 related to sex hormones? Semin Oncol 47(5):335\u2013340. https:\/\/doi.org\/10.1053\/j.seminoncol.2020.06.002","journal-title":"Semin Oncol"},{"issue":"1","key":"8032_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/mmbr.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP et al (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76(1):16\u201332. https:\/\/doi.org\/10.1128\/mmbr.05015-11","journal-title":"Microbiol Mol Biol Rev"},{"issue":"10223","key":"8032_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/s0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"5","key":"8032_CR26","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1365-2133.2008.08854.x","volume":"159","author":"M Saha","year":"2008","unstructured":"Saha M, Black MM, Groves RW (2008) Risk of herpes zoster infection in patients with pemphigus on mycophenolate mofetil. Br J Dermatol 159(5):1212\u20131213. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08854.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"8032_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-2133.1998.02048.x","volume":"138","author":"MG Haufs","year":"1998","unstructured":"Haufs MG, Beissert S, Grabbe S et al (1998) Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol 138(1):179\u2013181","journal-title":"Br J Dermatol"},{"issue":"1","key":"8032_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09546634.2019.1572864","volume":"31","author":"JSW Yun","year":"2020","unstructured":"Yun JSW, Yap T, Martyres R et al (2020) The association of mycophenolate mofetil and human herpes virus infection. J Dermatolog Treat 31(1):46\u201355. https:\/\/doi.org\/10.1080\/09546634.2019.1572864","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"8032_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050801","volume":"10","author":"M De Santis","year":"2022","unstructured":"De Santis M, Motta F, Isailovic N et al (2022) Dose-dependent impairment of the immune response to the Moderna-1273 mRNA vaccine by mycophenolate mofetil in patients with rheumatic and autoimmune liver diseases. Vaccines 10(5):801. https:\/\/doi.org\/10.3390\/vaccines10050801","journal-title":"Vaccines"},{"issue":"28","key":"8032_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2500276122","volume":"122","author":"TL Meister","year":"2025","unstructured":"Meister TL, Nocke MK, Heinen N et al (2025) Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants. Proc Natl Acad Sci U S A 122(28):2500276122. https:\/\/doi.org\/10.1073\/pnas.2500276122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8032_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14771","volume":"27","author":"F Abutiban","year":"2024","unstructured":"Abutiban F, Saleh K, Hayat S et al (2024) COVID-19 and reported mortality cases among rheumatic disease patients in Kuwait: data from the Global Rheumatology Alliance registry. Int J Rheum Dis 27(1):14771. https:\/\/doi.org\/10.1111\/1756-185x.14771","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"8032_CR32","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/art.1780390906","volume":"39","author":"BD Pryor","year":"1996","unstructured":"Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39(9):1475\u20131482. https:\/\/doi.org\/10.1002\/art.1780390906","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8032_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218244","volume":"80","author":"Z Gendebien","year":"2021","unstructured":"Gendebien Z, von Frenckell C, Ribbens C et al (2021) Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Ann Rheum Dis 80(6):94. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218244","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8032_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90797-0","volume":"11","author":"A Juli\u00e0","year":"2021","unstructured":"Juli\u00e0 A, Bonafonte-Pard\u00e0s I, G\u00f3mez A et al (2021) Targeting of the CD80\/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19. Sci Rep 11(1):11462. https:\/\/doi.org\/10.1038\/s41598-021-90797-0","journal-title":"Sci Rep"},{"issue":"11","key":"8032_CR35","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa050524","volume":"353","author":"MC Genovese","year":"2005","unstructured":"Genovese MC, Becker JC, Schiff M et al (2005) Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 353(11):1114\u20131123. https:\/\/doi.org\/10.1056\/NEJMoa050524","journal-title":"N Engl J Med"},{"issue":"10","key":"8032_CR36","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","volume":"27","author":"AC Medeiros-Ribeiro","year":"2021","unstructured":"Medeiros-Ribeiro AC, Aikawa NE, Saad CGS et al (2021) Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med 27(10):1744\u20131751. https:\/\/doi.org\/10.1038\/s41591-021-01469-5","journal-title":"Nat Med"},{"issue":"1","key":"8032_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW et al (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79(1):39\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215882","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8032_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01046-2","volume":"23","author":"W Tang","year":"2021","unstructured":"Tang W, Gartshteyn Y, Ricker E et al (2021) The use of COVID-19 vaccines in patients with SLE. Curr Rheumatol Rep 23(11):79. https:\/\/doi.org\/10.1007\/s11926-021-01046-2","journal-title":"Curr Rheumatol Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08032-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:24:51Z","timestamp":1780982691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08032-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8032"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08032-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}